PubMed:1505523
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-3 | DNA | denotes | TAR |
| T2 | 35-38 | protein | denotes | Tat |
| T3 | 118-129 | protein | denotes | Tat protein |
| T4 | 264-267 | protein | denotes | Tat |
| T5 | 383-397 | DNA | denotes | viral promoter |
| T6 | 703-706 | protein | denotes | Tat |
| T7 | 723-733 | RNA | denotes | RNA target |
| T8 | 741-744 | RNA | denotes | TAR |
| T9 | 746-772 | RNA | denotes | transactivation responsive |
| T10 | 821-832 | RNA | denotes | HIV-1 mRNAs |
| T11 | 975-992 | cell_line | denotes | CNS-derived cells |
| T12 | 993-996 | protein | denotes | Tat |
| T13 | 1038-1041 | DNA | denotes | TAR |
| T14 | 1065-1087 | DNA | denotes | Tat-responsive element |
| T15 | 1117-1131 | DNA | denotes | viral promoter |
| T16 | 1140-1164 | cell_line | denotes | glial-derived cell lines |
| T17 | 1206-1209 | RNA | denotes | TAR |
| T18 | 1232-1258 | DNA | denotes | hybrid promoter constructs |
| T19 | 1297-1319 | DNA | denotes | Tat-responsive element |
| T20 | 1357-1383 | DNA | denotes | viral long terminal repeat |
| T21 | 1385-1388 | DNA | denotes | LTR |
| T22 | 1419-1433 | DNA | denotes | HIV-1 enhancer |
| T23 | 1438-1455 | DNA | denotes | NF-kappa B domain |
| T24 | 1489-1499 | protein | denotes | NF-kappa B |
| T25 | 1566-1582 | cell_type | denotes | T lymphoid cells |
| T26 | 1609-1628 | DNA | denotes | TAR-deleted mutants |
| T27 | 1681-1692 | cell_type | denotes | glial cells |
| T28 | 1746-1763 | protein | denotes | viral p24 antigen |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-31 | NP | denotes | TAR-independent transactivation |
| C2 | 35-38 | NP | denotes | Tat |
| C3 | 42-68 | NP | denotes | cells derived from the CNS |
| C4 | 91-96 | NP | denotes | HIV-1 |
| C6 | 133-176 | NP | denotes | human immunodeficiency virus type 1 (HIV-1) |
| C5 | 114-176 | NP | denotes | The Tat protein of human immunodeficiency virus type 1 (HIV-1) |
| C7 | 264-267 | NP | denotes | Tat |
| C9 | 291-296 | NP | denotes | HIV-1 |
| C8 | 269-312 | NP | denotes | a potent activator of HIV-1 gene expression |
| C10 | 379-397 | NP | denotes | the viral promoter |
| C11 | 399-413 | NP | denotes | This induction |
| C12 | 415-420 | NP | denotes | which |
| C13 | 536-610 | NP | denotes | increased transcriptional initiation, increased transcriptional elongation |
| C14 | 632-647 | NP | denotes | these processes |
| C15 | 703-706 | NP | denotes | Tat |
| C16 | 712-773 | NP | denotes | a specific RNA target termed TAR (transactivation responsive) |
| C17 | 774-779 | NP | denotes | which |
| C18 | 821-826 | NP | denotes | HIV-1 |
| C19 | 967-992 | NP | denotes | certain CNS-derived cells |
| C20 | 993-996 | NP | denotes | Tat |
| C21 | 1022-1027 | NP | denotes | HIV-1 |
| C22 | 1063-1087 | NP | denotes | A Tat-responsive element |
| C23 | 1113-1131 | NP | denotes | the viral promoter |
| C24 | 1132-1136 | NP | denotes | that |
| C25 | 1206-1209 | NP | denotes | TAR |
| C26 | 1276-1319 | NP | denotes | the newly identified Tat-responsive element |
| C28 | 1419-1424 | NP | denotes | HIV-1 |
| C27 | 1415-1433 | NP | denotes | the HIV-1 enhancer |
| C29 | 1438-1455 | NP | denotes | NF-kappa B domain |
| C31 | 1489-1516 | NP | denotes | NF-kappa B binding activity |
| C32 | 1520-1531 | NP | denotes | glial cells |
| C30 | 1489-1531 | NP | denotes | NF-kappa B binding activity in glial cells |
| C33 | 1532-1536 | NP | denotes | that |
| C34 | 1550-1554 | NP | denotes | that |
| C35 | 1632-1637 | NP | denotes | HIV-1 |
| C36 | 1681-1692 | NP | denotes | glial cells |
| R1 | C6 | C4 | coref-ident | human immunodeficiency virus type 1 (HIV-1),HIV-1 |
| R2 | C5 | C2 | coref-ident | The Tat protein of human immunodeficiency virus type 1 (HIV-1),Tat |
| R3 | C7 | C5 | coref-ident | Tat,The Tat protein of human immunodeficiency virus type 1 (HIV-1) |
| R4 | C9 | C6 | coref-ident | HIV-1,human immunodeficiency virus type 1 (HIV-1) |
| R5 | C8 | C7 | coref-appos | a potent activator of HIV-1 gene expression,Tat |
| R6 | C12 | C11 | coref-relat | which,This induction |
| R7 | C14 | C13 | coref-ident | these processes,"increased transcriptional initiation, increased transcriptional elongation" |
| R8 | C15 | C7 | coref-ident | Tat,Tat |
| R9 | C17 | C16 | coref-relat | which,a specific RNA target termed TAR (transactivation responsive) |
| R10 | C18 | C9 | coref-ident | HIV-1,HIV-1 |
| R11 | C19 | C3 | coref-ident | certain CNS-derived cells,cells derived from the CNS |
| R12 | C20 | C15 | coref-ident | Tat,Tat |
| R13 | C21 | C18 | coref-ident | HIV-1,HIV-1 |
| R14 | C23 | C10 | coref-ident | the viral promoter,the viral promoter |
| R15 | C24 | C23 | coref-relat | that,the viral promoter |
| R16 | C25 | C16 | coref-ident | TAR,a specific RNA target termed TAR (transactivation responsive) |
| R17 | C26 | C22 | coref-ident | the newly identified Tat-responsive element,A Tat-responsive element |
| R18 | C28 | C21 | coref-ident | HIV-1,HIV-1 |
| R19 | C29 | C27 | coref-other | NF-kappa B domain,the HIV-1 enhancer |
| R20 | C33 | C30 | coref-relat | that,NF-kappa B binding activity in glial cells |
| R21 | C34 | C31 | coref-pron | that,NF-kappa B binding activity |
| R22 | C35 | C28 | coref-ident | HIV-1,HIV-1 |
| R23 | C36 | C32 | coref-ident | glial cells,glial cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-113 | Sentence | denotes | TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. |
| S2 | 114-263 | Sentence | denotes | The Tat protein of human immunodeficiency virus type 1 (HIV-1) is essential for productive infection and is a potential target for antiviral therapy. |
| S3 | 264-398 | Sentence | denotes | Tat, a potent activator of HIV-1 gene expression, serves to greatly increase the rate of transcription directed by the viral promoter. |
| S4 | 399-648 | Sentence | denotes | This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes. |
| S5 | 649-833 | Sentence | denotes | Much attention has been focused on the interaction of Tat with a specific RNA target termed TAR (transactivation responsive) which is present in the leader sequence of all HIV-1 mRNAs. |
| S6 | 834-928 | Sentence | denotes | This interaction is believed to be an important component of the mechanism of transactivation. |
| S7 | 929-1062 | Sentence | denotes | In this report we demonstrate that in certain CNS-derived cells Tat is capable of activating HIV-1 through a TAR-independent pathway. |
| S8 | 1063-1210 | Sentence | denotes | A Tat-responsive element is found upstream within the viral promoter that in glial-derived cell lines allows transactivation in the absence of TAR. |
| S9 | 1211-1456 | Sentence | denotes | Deletion mapping and hybrid promoter constructs demonstrate that the newly identified Tat-responsive element corresponds to a sequence within the viral long terminal repeat (LTR) previously identified as the HIV-1 enhancer, or NF-kappa B domain. |
| S10 | 1457-1583 | Sentence | denotes | DNA band-shift analysis reveals NF-kappa B binding activity in glial cells that differs from that present in T lymphoid cells. |
| S11 | 1584-1764 | Sentence | denotes | Further, we observe that TAR-deleted mutants of HIV-1 demonstrate normal late gene expression in glial cells as evidenced by syncytia formation and production of viral p24 antigen. |
| S12 | 1764-1797 | Sentence | denotes | (ABSTRACT TRUNCATED AT 250 WORDS) |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-3 | DNA_domain_or_region | denotes | TAR |
| T2 | 35-38 | protein_molecule | denotes | Tat |
| T3 | 91-96 | virus | denotes | HIV-1 |
| T4 | 118-129 | protein_molecule | denotes | Tat protein |
| T5 | 133-168 | virus | denotes | human immunodeficiency virus type 1 |
| T6 | 170-175 | virus | denotes | HIV-1 |
| T7 | 245-262 | other_name | denotes | antiviral therapy |
| T8 | 264-267 | protein_molecule | denotes | Tat |
| T9 | 291-296 | virus | denotes | HIV-1 |
| T10 | 353-366 | other_name | denotes | transcription |
| T11 | 383-397 | DNA_domain_or_region | denotes | viral promoter |
| T12 | 478-513 | other_name | denotes | acquired immune deficiency syndrome |
| T13 | 515-519 | other_name | denotes | AIDS |
| T14 | 536-572 | other_name | denotes | increased transcriptional initiation |
| T15 | 584-610 | other_name | denotes | transcriptional elongation |
| T16 | 703-706 | protein_molecule | denotes | Tat |
| T17 | 723-733 | RNA_family_or_group | denotes | RNA target |
| T18 | 741-744 | RNA_domain_or_region | denotes | TAR |
| T19 | 746-772 | RNA_domain_or_region | denotes | transactivation responsive |
| T20 | 821-832 | RNA_family_or_group | denotes | HIV-1 mRNAs |
| T21 | 899-927 | other_name | denotes | mechanism of transactivation |
| T22 | 975-992 | cell_line | denotes | CNS-derived cells |
| T23 | 993-996 | protein_molecule | denotes | Tat |
| T24 | 1022-1027 | virus | denotes | HIV-1 |
| T25 | 1038-1041 | DNA_domain_or_region | denotes | TAR |
| T26 | 1065-1068 | protein_molecule | denotes | Tat |
| T27 | 1117-1131 | DNA_domain_or_region | denotes | viral promoter |
| T28 | 1140-1164 | cell_line | denotes | glial-derived cell lines |
| T29 | 1206-1209 | RNA_domain_or_region | denotes | TAR |
| T30 | 1232-1258 | DNA_family_or_group | denotes | hybrid promoter constructs |
| T31 | 1297-1300 | protein_molecule | denotes | Tat |
| T32 | 1357-1383 | DNA_domain_or_region | denotes | viral long terminal repeat |
| T33 | 1385-1388 | DNA_domain_or_region | denotes | LTR |
| T34 | 1419-1424 | virus | denotes | HIV-1 |
| T35 | 1438-1455 | DNA_domain_or_region | denotes | NF-kappa B domain |
| T36 | 1457-1480 | other_name | denotes | DNA band-shift analysis |
| T37 | 1489-1499 | protein_molecule | denotes | NF-kappa B |
| T38 | 1566-1582 | cell_type | denotes | T lymphoid cells |
| T39 | 1609-1628 | DNA_family_or_group | denotes | TAR-deleted mutants |
| T40 | 1632-1637 | virus | denotes | HIV-1 |
| T41 | 1650-1677 | other_name | denotes | normal late gene expression |
| T42 | 1681-1692 | cell_type | denotes | glial cells |
| T43 | 1709-1727 | other_name | denotes | syncytia formation |
| T44 | 1746-1763 | protein_molecule | denotes | viral p24 antigen |